Unichem Laboratories Balance Sheet Health
Financial Health criteria checks 5/6
Unichem Laboratories has a total shareholder equity of ₹24.0B and total debt of ₹2.7B, which brings its debt-to-equity ratio to 11.2%. Its total assets and total liabilities are ₹33.1B and ₹9.1B respectively. Unichem Laboratories's EBIT is ₹526.1M making its interest coverage ratio 3. It has cash and short-term investments of ₹2.0B.
Key information
11.2%
Debt to equity ratio
₹2.68b
Debt
| Interest coverage ratio | 3x |
| Cash | ₹1.98b |
| Equity | ₹24.01b |
| Total liabilities | ₹9.10b |
| Total assets | ₹33.11b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 506690's short term assets (₹18.3B) exceed its short term liabilities (₹8.2B).
Long Term Liabilities: 506690's short term assets (₹18.3B) exceed its long term liabilities (₹907.1M).
Debt to Equity History and Analysis
Debt Level: 506690's net debt to equity ratio (2.9%) is considered satisfactory.
Reducing Debt: 506690's debt to equity ratio has increased from 7.3% to 11.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 506690 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 506690 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 33.6% per year.